NDC 0169-3004 – Novolin N

Insulin Human 100 [iU]/mL · Injection, Suspension · Subcutaneous

Human Otc Drug

Product NDC0169-3004

Product details

Brand name
Novolin N
Generic name
Human Insulin
Labeler
Novo Nordisk
Dosage form
Injection, Suspension
Route
Subcutaneous
Marketing category
BLA · BLA019959
Marketed since
September 6, 2019
Listing expires
December 31, 2026
Pharmacologic class
Insulin

Active ingredients

Uses, dosage, side effects and warnings for Novolin →

Package NDC codes (2)

Package NDCDescriptionSince
0169-3004-155 SYRINGE, PLASTIC in 1 CARTON (0169-3004-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3004-01)Sep 6, 2019
0169-3004-255 SYRINGE, PLASTIC in 1 CARTON (0169-3004-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3004-12)Sep 6, 2019

Other Novolin products